Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Novel therapies in the management of type I diabetes mellitus.

Ludvigsson J.

Panminerva Med. 2012 Dec;54(4):257-70. Review.

PMID:
23123577
2.

Diabetes technology and treatments in the paediatric age group.

Shalitin S, Peter Chase H.

Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Review.

PMID:
21323816
3.

The role of immunomodulation therapy in autoimmune diabetes.

Ludvigsson J; Linköping Diabetes Immune Intervention Study Group.

J Diabetes Sci Technol. 2009 Mar 1;3(2):320-30. Review.

4.

Immune modulation in type 1 diabetes mellitus using DiaPep277: a short review and update of recent clinical trial results.

Eldor R, Kassem S, Raz I.

Diabetes Metab Res Rev. 2009 May;25(4):316-20. doi: 10.1002/dmrr.942. Review.

PMID:
19267355
5.

Clinical requirements for closed-loop control systems.

Clarke WL, Renard E.

J Diabetes Sci Technol. 2012 Mar 1;6(2):444-52. Review.

6.

Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.

Fändrich F, Ungefroren H.

Adv Exp Med Biol. 2010;654:641-65. doi: 10.1007/978-90-481-3271-3_28. Review.

PMID:
20217518
7.

GAD-alum (Diamyd)--a new concept for preservation of residual insulin secretion.

Ludvigsson J.

Expert Opin Biol Ther. 2010 May;10(5):787-99. doi: 10.1517/14712591003742920. Review.

PMID:
20230187
8.

From pumps to prevention: recent advances in the treatment of type 1 diabetes.

Sherr J, Cengiz E, Tamborlane WV.

Drug Discov Today. 2009 Oct;14(19-20):973-81. doi: 10.1016/j.drudis.2009.06.011. Epub 2009 Jul 4. Review.

PMID:
19580883
9.

Combination therapy for preservation of beta cell function in Type 1 diabetes: new attitudes and strategies are needed!

Ludvigsson J.

Immunol Lett. 2014 May-Jun;159(1-2):30-5. doi: 10.1016/j.imlet.2014.02.006. Epub 2014 Feb 24. Review.

PMID:
24576850
10.

Deus ex machina: the use of technology in type 1 diabetes.

Kerr D, Partridge H.

Prim Care Diabetes. 2011 Oct;5(3):159-65. doi: 10.1016/j.pcd.2010.11.001. Epub 2011 Jul 2. Review.

PMID:
21727052
11.

Insulin therapy in type 2 diabetes.

Mudaliar S, Edelman SV.

Endocrinol Metab Clin North Am. 2001 Dec;30(4):935-82. Review.

PMID:
11727406
12.

[Survey of recent clinical trials of the prevention and immunointervention of type 1 diabetes mellitus].

Boerschmann H, Walter M, Achenbach P, Ziegler AG.

Dtsch Med Wochenschr. 2010 Feb;135(8):350-4. doi: 10.1055/s-0030-1249169. Epub 2010 Feb 17. Review. German.

PMID:
20166000
13.

Emerging diabetes therapies and technologies.

Moser EG, Morris AA, Garg SK.

Diabetes Res Clin Pract. 2012 Jul;97(1):16-26. doi: 10.1016/j.diabres.2012.01.027. Epub 2012 Feb 29. Review.

PMID:
22381908
14.

Glycemic management of diabetes by insulin therapy.

Reix N, Sigrist S, Heurtault B, Agin A, Moreau F, Pinget M, Jeandidier N.

Minerva Endocrinol. 2013 Mar;38(1):29-46. Review.

PMID:
23435441
15.

Therapy with GAD in diabetes.

Ludvigsson J.

Diabetes Metab Res Rev. 2009 May;25(4):307-15. doi: 10.1002/dmrr.941. Review.

PMID:
19267332
16.

Clinical update on the use of immuno modulators (antiCD3, GAD, Diapep277, anti-IL1) in type 1 diabetes.

Pozzilli P, Guglielmi C, Maggi D, Carlone A, Buzzetti R, Manfrini S.

Curr Pharm Des. 2011;17(29):3224-8. Review.

PMID:
21864261
17.

Something old, something new and something very old: drugs for treating type 2 diabetes.

Kaiser D, Oetjen E.

Br J Pharmacol. 2014 Jun;171(12):2940-50. doi: 10.1111/bph.12624. Review.

18.

[C-peptide residual secretion makes difference on type 1 diabetes management?].

Rodacki M, Milech A, Oliveira JE.

Arq Bras Endocrinol Metabol. 2008 Mar;52(2):322-33. Review. Portuguese.

19.

New ways of insulin delivery.

Heinemann L.

Int J Clin Pract Suppl. 2010 Feb;(166):29-40. doi: 10.1111/j.1742-1241.2009.02276.x. Review.

PMID:
20377662
20.

2011 Update: antigen-specific therapy in type 1 diabetes.

Michels AW, von Herrath M.

Curr Opin Endocrinol Diabetes Obes. 2011 Aug;18(4):235-40. doi: 10.1097/MED.0b013e32834803ae. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk